|(1) The product passes quality control evaluation from a designated independent quality assurance auditor.
||(1) Initial testing pre-scale up, repeat if manufacturing process changes; periodic spot-checks
||(1) National authority review, local bylaw mandate documentation
||(1) Knowledgeable and unprejudicial national, and independent assessors.
|(2) Staff trained on product use and are able to demonstrate knowledge of correct use of MHM2 Innovative Product.
||(2) Beginning of scale up; repeat at interim to identify if retraining needed
||(2) Training logs; assessment forms of trained personnel
||(2) Accurate count of all trained; accurate questions used to demonstrate correct knowledge
|(1) Number of units of product manufactured per month; Number of units distributed by location [country/area] or vendor type.
||(1) Monthly or quarterly; summarize annually.
||(1) Company manufacturing, inventory, and distribution logs; vendor stock-check
||(1) Quality of auditing (spot-checks) of manufacturing and distribution logs that ensure quality of reporting
|(1) Number and type of individuals trained on debunking MHM myths and taboos
||(1) Beginning of program; repeat assessment at interim to identify if retraining needed
||(1) Training logs; periodic assessment of trained cadre
||(1) Accurate count of all trained; representative sampling of trained; accurate questions used to demonstrate correct knowledge around local myths and taboos
|(1) Number of beneficiaries’ and groups reporting: Innovative MHM Product is available and accessible to them, by area
||(1) Annual measure showing permeation.
||(1) Quantitative: Survey of beneficiaries and caregivers documenting MHM product is available and accessible to them in their community; vendors.
||(1) Representative of beneficiaries; stratified by target populations, girls, women, in-out of school, occupation, rural/urban, hard to reach.